|
Status |
Public on Sep 15, 2015 |
Title |
NS021_tumour |
Sample type |
genomic |
|
|
Source name |
tissue core
|
Organism |
Homo sapiens |
Characteristics |
sample type: tumour tumour gleason: 8=3+5 tumour %: 80% (derived data) iclusterplus group: N/A extra-capsular extension (ece): unknown positive surgical margins (psm): N biochemical relapse (bcr): N/A time to bcr (months): N/A tmprss2: ERG gene fusion status: unknown age at diag: 93 psa at diag: 282 pathology stage: UNKNOWN
|
Treatment protocol |
When available (i.e not CRPC samples), matched tumour and benign tissues were identified and prepared from RP surgical tissue as described in Warren et al. (2013). The Prostate. 73: 194-202. Matched whole blood samples were obtained from selected samples at treatment clinics.
|
Growth protocol |
N/A - surgical tissue or whole blood samples
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Qiagen AllPrep, according to manufacturer's instructions.
|
Label |
Cy3 and Cy5
|
Label protocol |
Standard Illumina label protocol; samples run by AROS (Denmark)
|
|
|
Hybridization protocol |
Standard Illumina hyb protocol; samples run by AROS (Denmark)
|
Scan protocol |
Standard Illumina scan protocol; samples run by AROS (Denmark)
|
Description |
chTURP (channel transurethral resection of the prostate) tissue from patient NS021_T A1942_rerun_processed_data.txt, column NS021_T
|
Data processing |
Data were pre-processed and quality checked using ‘Call Rate QC’ (AROS), gender calls from PennCNV (Wang et al., 2007); sample pairings were confirmed using BADGER (Lynch et al., 2012).
|
|
|
Submission date |
Sep 14, 2015 |
Last update date |
Dec 01, 2015 |
Contact name |
Chandra Chilamakuri |
E-mail(s) |
datasubmissions@cruk.cam.ac.uk
|
Organization name |
Cancer Research UK Cambridge Institute
|
Street address |
Robinson Way
|
City |
Cambridge |
ZIP/Postal code |
CB2 0RE |
Country |
United Kingdom |
|
|
Platform ID |
GPL16104 |
Series (2) |
GSE70770 |
Prostate cancer stratification using molecular profiles |
GSE73012 |
Prostate cancer stratification using molecular profiles [CamCap genotype third set] |
|